NEW HAVEN, Conn., Jan. 9, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") announced positive results today from its bioequivalence study ...
SOMERSET, NJ, February 15, 2011 - Catalent Pharma Solutions, the world's leading provider of advanced oral drug delivery technologies and solutions, announced that it has entered into a license ...
Adding to its store of technology weapons, Catalent Pharma can now offer fast-dissolve tablet technology to clients. It obtained the development rights to Lyopan from Pantec. The lyophilized tablets ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced it recently entered into an ...
Catalent's Zydis ® orally disintegrating tablet (ODT) fast-dissolve formulation is a unique, freeze-dried oral dosage form that disperses instantly in the mouth, requiring no water. With more than 20 ...
The FDA has approved the world's first 3D-printed drug Spritam, a fast-dissolving tablet that can be printed up to 1,000mg to make it easier for epilepsy patients to swallow Aprecia Pharmaceuticals ...
The authors formulated and developed taste-masked RDFs of cetirizine hydrochloride for patients who experience difficulty in swallowing the tablet dosage form of the drug. Rapidly dissolving dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback